Navigation Links
Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers' Movie to Be Filmed About Him
Date:3/25/2008

See Related Website at http://www.markwhitacre.com

FRESNO, Calif., March 25 /PRNewswire/ -- Cypress Systems, Inc., a Fresno, CA based biotechnology company, announced that it has promoted Mark E. Whitacre, Ph.D. to become the company's Chief Operating Officer (COO) and President of Operations. Dr. Whitacre joined the executive management team in December 2006 as President of Technology and Business Development for the new East Coast office. The company's CEO & President, Paul A. Willis, stated that, "By having Mark Whitacre as a part of the management team, we have taken a significant step in our effort to expand our selenium based cancer prevention research and to develop next generation products. Dr. Whitacre's research and top-management business experience has fully aligned with the future direction of the company and its continued expansion into fermentation technology with emphasis on biotechnology and life science applications. In the fifteen months since Dr. Whitacre joined the company, he has proven to be a valuable part of the management team."

*(PHOTO 72dpi: Send2Press.com/mediaboom/08-0325-MWhitacre_72dpi.jpg)

*(Photo Caption: Mark Whitacre.)

In an effort to provide greater detail related to Dr. Whitacre's extensive education, research accomplishments, management experience, professional career, and his current work with Cypress, the company launched a biography website at http://www.markwhitacre.com last year. Dr. Whitacre's education includes B.S. and Master's degrees from Ohio State University and a Ph.D. in Nutritional Biochemistry from Cornell University where Mark's Ph.D. thesis adviser was a renowned selenium researcher, Dr. G.F. Combs, Jr. Dr. Whitacre's research at Cornell University related to the biochemical role of selenium at the cellular level in the prevention of diseases. Mark continue
'/>"/>

SOURCE Cypress Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. USANAs CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporations Board of Directors
2. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
3. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
4. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
5. Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors
6. BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
7. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
8. Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
9. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
10. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
11. Cylene Pharmaceuticals Appoints Kenna Anderes, Ph.D. as Vice President of Cancer Biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... ended March 31, 2015.  Biorem,s complete 2015 first quarter financial statements ... Financial Summary:Three-months ended March 31,(in CDN$,000 except per ... 4,689 , 1,974 Gross profit , 1,531 ... (318) Net earnings (loss) , 528 , (531) ...
(Date:6/1/2015)... , June 1, 2015 ... announced the addition of the "Global PDT ... offering.        (Logo: ... Report 2014 is a professional and in-depth study ... , ,The report provides a basic overview of ...
(Date:6/1/2015)... Regis Technologies, Inc. is a ... stationary phases (CSPs) for analytical and preparative chromatography ... presenting solutions for new clients, Regis implemented a ... addition to its core expertise in chiral chromatography ... tackle projects for the scale clients need–from milligram ...
(Date:6/1/2015)... RESEARCH TRIANGLE PARK, N.C. , June 1, ... FENCF), announced the presentation of positive interim results ... in SIOPEL6: A multi-centre open label randomised phase ... (STS) in reducing ototoxicity in patients receiving cisplatin ... data was presented at the American Society of ...
Breaking Biology Technology:Biorem Reports Increased Revenues and Earnings for First Quarter 2Biorem Reports Increased Revenues and Earnings for First Quarter 3Global PDT Machine Industry Report 2014 2Regis Technologies Offers Chiral Chromatography Service 2Regis Technologies Offers Chiral Chromatography Service 3Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 2Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 3Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 4
... Inc., (Nasdaq: MGRM ) announced that it will ... 4:30 p.m. (Eastern Time) to discuss,third quarter 2007 financial ... Young, Chairman and CEO of Monogram. To participate ... 325-4878 for international callers, fifteen minutes before the,conference begins. ...
... Oct. 17 Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) ... 30, 2007. Total revenues in the third quarter ... the third quarter of 2006. Total revenues in the ... $25.9 million in the,first nine months of 2006. Revenues ...
... Diplomat Health Services,in conjunction with McLaren Health Plan, ... Genzyme, announced today the results of its,pilot program ... The,program managed chronic kidney disease patients for McLaren ... savings of $300 per patient per,month compared to ...
Cached Biology Technology:Monogram Biosciences Announces Third Quarter 2007 Financial Results Conference Call 2Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 2Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 3Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 4Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 5Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 6Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 7Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management 2
(Date:5/22/2015)... May 22, 2015 According to ... Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, Databases), ... and Utilities, Consumer and Home) - Global Forecast to ... from $2.77 Billion in 2015 to $6.19 Billion by ... Browse 79 market data Tables and   43 Figures ...
(Date:5/19/2015)... Fingerprint Cards (FPC) has received an order for ... from one if its module partners. Deliveries are planned to ... the sensors will be used by smartphone manufacturers in ... amount to 740 MSEK to date. In addition to previously ... number of smaller orders not separately communicated amounting to more ...
(Date:5/14/2015)... NEW YORK , May 14, 2015 ... specializing in identity verification and online remote ... Instructure, a software-as-a-service (SaaS) company and creator ... Shared customers of the two companies will ... Proctortrack in Canvas. As a ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... developed in part by DOE,s Oak Ridge National Laboratory ... threats of insects, disease and wildfire. Led by ... computing to incorporate remote sensing data from NASA satellites ... abnormal vegetation patterns and the timing of seasonal changes. ...
... of Understanding signed today, the European Commission (EC) and ... to maintain and further develop their cooperation. , "I ... of Understanding between the European Commission and the European ... set the stage for even better and more fruitful ...
... , This release is available in Spanish ... Linoleico Conjugado y Resvetratrol: efecto de estos ingredientes funcionales sobre ... Linoleic Acid and Resveratrol: the effect of these functional ingredients ... research team member at the University of the Basque Country ...
Cached Biology News:Resveratrol may be useful tool for reducing body fat 2
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
One-step, microplate or cuvet, turbidometric, linear detection range 0.096 mg/dL to 11.5 mg/dL. Procedure: 5 min....
Moue Serum 8-12 Weeks Old...
... • Mouse serum is collected off the clot fasted ... of age. Available Anticoagulants: N-02: ... K2EDTA N-08: Potassium Oxalate N-10: ... ACD N-07: CPD N-09: K3EDTA ...
Biology Products: